Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus vaginal probiotics for postmenopausal symptoms
IRCT20241004063255N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sertraline in menopause (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Reduction in menopausal symptom severity. Started Jan 2025; status: completed.
02
Drugs
sertraline
03
Conditions
menopause
Beyond the preview
Go deeper on IRCT20241004063255N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241004063255N1.